MIRM — Mirum Pharmaceuticals, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1759425 ·
Last close
$91.95
Market Cap
$6.00B
52W High
$130.00
52W Low
$63.23
ADV30
664,039
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 185,721,000 | 150,549,000 | -46,246,000 | -40,766,000 | 1,026,613,000 | 243,188,000 | 1,080,799,000 |
| Jun 2026 | 176,243,000 | 145,895,000 | -26,102,000 | -67,227,000 | 1,044,981,000 | 330,728,000 | 1,055,403,000 |
| Mar 2026 | 159,882,000 | 131,077,000 | -63,163,000 | -790,155,000 | 890,916,000 | 324,907,000 | 648,422,000 |
| Dec 2025 | 148,932,000 | 120,668,000 | -4,567,000 | -5,730,000 | 842,813,000 | 296,683,000 | 528,123,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-271,259,000
Investing CF
$-199,422,000
Financing CF
$436,173,000
CapEx
$-37,592,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-15.47
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,565,692,000
Inventory
$25,486,000
Receivables
$156,348,000
ST Investments
$130,499,000
EBIT TTM
$-888,971,000
Pretax Income TTM
$-900,409,000
Interest Exp TTM
$11,438,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$670,777,984
EBITDA
$-118,305,000
Free Cash Flow
$98,386,496
Enterprise Value
$6,488,108,032
Total Cash
$373,687,008
Total Debt
$743,561,984
Shares Out
65,282,044
Trailing EPS
$-14.47
Book Value
$-0.83
ROE
-760.0%
ROA
-10.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 521,312,000 | -22,136,000 | -23,363,000 | 842,813,000 | 528,123,000 | 314,690,000 | 55,827,000 |
| Dec 2024 | 336,888,000 | -87,606,000 | -87,942,000 | 670,754,000 | 445,114,000 | 225,640,000 | 10,325,000 |
| Dec 2023 | 186,374,000 | -109,154,000 | -163,415,000 | 646,621,000 | 397,951,000 | 248,670,000 | -70,944,000 |
| Dec 2022 | 77,062,000 | -131,220,000 | -135,665,000 | 352,906,000 | 210,869,000 | 142,037,000 | -120,136,000 |
TTM Snapshot
Revenues TTM
$618,067,000
NetIncome TTM
$-860,207,000
OpCashFlow TTM
—
Assets (Latest)
$1,044,981,000
Forward EPS
$0.32
Max Pain — expiry 2026-12-18
max pain strike: $85.00 · spot: $92.49 · call oi: 1,310 · put oi: 496
Expected Move to 2026-12-18:
±$9.40
(10.16%) —
implied range
$83.09 –
$101.89
· ATM straddle on $90.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $6.08B | $42.99 | — |
| LGND | LIGAND PHARMACEUTICALS INC | $5.86B | $293.81 | — |
| BLTE | BELITE BIO, INC | $6.35B | $157.72 | — |
| ORKA | Oruka Therapeutics, Inc. | $6.53B | $96.32 | — |
| GIFLF | Grifols SA | $5.37B | $12.72 | — |
News headlines (Yahoo Finance, 1h cache)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-12 21:01 · Yahoo
Mirum Pharmaceuticals Announces Primary Endpoint Met in AZURE-4 Phase 3 Study and Highlights Long-Term Brelovitug Data Presented at AASLD
2026-11-10 12:30 · Yahoo
No Cost Exome Testing Could Be A Game Changer For GeneDx (WGS)
2026-11-07 10:16 · Yahoo
GeneDx and Mirum to provide genetic tests for cholestasis, cataracts or PBD-ZSD
2026-11-06 11:03 · Yahoo
GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing
2026-11-05 13:30 · Yahoo
Why Mirum Pharmaceuticals (MIRM) Is Up 11.4% And What's Next After Earnings Beat
2026-11-05 04:42 · Yahoo
Mirum (MIRM) Q3 2026 Earnings Call Transcript
2026-11-04 15:29 · Yahoo
Mirum Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
2026-11-04 13:30 · Yahoo
Mirum Pharmaceuticals Q3 Earnings Call Highlights
2026-11-04 02:14 · Yahoo
Here's What Key Metrics Tell Us About Mirum Pharmaceuticals (MIRM) Q3 Earnings
2026-11-03 21:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.